Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-0450PMID 16778199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma cholecystokinin and neurotensin after an ordinary meal in humans. A prolonged time study.

  2008cited by this paper
• Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.

  2006influential reference
• Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer

  2005cited by this paper
• Global trends in breast cancer incidence and mortality 1973-1997.

  2005influential reference
• Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.

  2004cited by this paper
• Metalloproteinase-dependent Transforming Growth Factor-α Release Mediates Neurotensin-stimulated MAP Kinase Activation in Human Colonic Epithelial Cells*

  2004cited by this paper
• Wnt Signaling and Breast Cancer

  2004cited by this paper
• Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis

  2004cited by this paper
• Receptor Trafficking via the Perinuclear Recycling Compartment Accompanied by Cell Division Is Necessary for Permanent Neurotensin Cell Sensitization and Leads to Chronic Mitogen-activated Protein Kinase Activation*

  2004cited by this paper
• Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways.

  2003cited by this paper
• Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues.

  2003cited by this paper
• Serum peptide profiles in patients with carcinoid tumors.

  2003cited by this paper
• Identification of genes associated with enhanced metastasis of a large cell lung carcinoma cell line.

  2003cited by this paper
• Neuropeptides as growth factors for normal and cancerous cells.

  2002cited by this paper
• Endocrine Gene Neurotensin: Molecular Mechanisms and a Model of Intestinal Differentiation

  2002cited by this paper
• Matrix metalloproteinases in tumor invasion: Role for cell migration

  2002cited by this paper
• Neurotensin counteracts apoptosis in breast cancer cells.

  2002cited by this paper
• Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells.

  2002cited by this paper
• Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF‐I and EGF

  2002cited by this paper
• SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients

  2001cited by this paper
• The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.

  2001cited by this paper
• New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades

  2001cited by this paper
• G-protein-coupled receptors and signaling networks: emerging paradigms.

  2001cited by this paper
• Signal Transduction Pathways Mediating Neurotensin-stimulated Interleukin-8 Expression in Human Colonocytes*

  2001cited by this paper
• Collagen invasion assay.

  2001cited by this paper
• Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers.

  2000cited by this paper
• Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease.

  2000cited by this paper
• Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2.

  2000cited by this paper
• Relevant genomics of neurotensin receptor in cancer.

  2000cited by this paper
• Neurotensin: peptide for the next millennium.

  2000cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Transcriptional Effects of Estrogen on Neuronal Neurotensin Gene Expression Involve cAMP/Protein Kinase A-Dependent Signaling Mechanisms

  1998cited by this paper
• Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.

  1997cited by this paper
• Src-mediated activation of the human neurotensin/neuromedin N promoter.

  1997cited by this paper
• Neurotensin Agonist Induces Differential Regulation of Neurotensin Receptor mRNA

  1997cited by this paper
• Fetal and neoplastic expression of the neurotensin gene in the human colon.

  1996cited by this paper
• Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

  1993influential reference
• HER-2/neu amplification predicts poor survival in node-positive breast cancer.

  1990cited by this paper
• Postprandial levels of prolactin and gut hormones in breast cancer patients: association with stage of disease, but not dietary fat.

  1990cited by this paper
• Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture.

  1986cited by this paper
• Neurotensin stimulates [3H]oleic acid translocation across rat small intestine.

  1986cited by this paper
• Neurotensin: Immunohistochemical Localization in Central and Peripheral Nervous System and in Endocrine Cells and its Functional Role as Neurotransmitter and Endocrine Hormone

  1985cited by this paper
• Neurotensinlike immunoreactivity in plasma and tumor tissue from patients with endocrine tumors of the pancreas and gut.

  1983cited by this paper
• Effect of neurotensin on exocrine pancreatic secretion in dogs.

  1982cited by this paper
• Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin.

  1977cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Advances in intratumoral immunotherapy from a neuro-immune-endocrine perspective for breast cancer treatment.

  2026cites this paper
• Bioelectric Membrane Potential and Breast Cancer: Advances in Neuroreceptor Pharmacology for Targeted Therapeutic Strategies

  2025cites this paper
• Reshaping [99mTc]Tc-DT11 to DT14D Tagged with Trivalent Radiometals for NTS1R-Positive Cancer Theranostics

  2025cites this paper
• A Novel Radiotracer for NTSR1-Targeted PET Imaging of Tumor: Preclinical and First-in-Human Studies.

  2025cites this paper
• The Involvement of the Peptidergic Systems in Breast Cancer Development

  2025cites this paper
• 99mTc-Labeled Diarylpyrazoles for Single-Emission Computer Tomography Imaging of Neurotensin Receptor-Positive Tumors: A Comparative Preclinical Study

  2025cites this paper
• Neurotensin and Its Involvement in Female Hormone-Sensitive Cancers

  2024influential citation
• Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor

  2024cites this paper
• IL-4, IL-7, IL-9, NT, NRP1 May Be Useful Markers in the Diagnosis of Endometrial Cancer

  2024cites this paper
• Toward Stability Enhancement of NTS1R-Targeted Radioligands: Structural Interventions on [99mTc]Tc-DT1

  2023cites this paper
• Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions

  2023cites this paper
• Side-Chain Modified [99mTc]Tc-DT1 Mimics: A Comparative Study in NTS1R-Positive Models

  2023cites this paper
• NTSR1 glycosylation and MMP dependent cleavage generate three distinct forms of the protein

  2023cites this paper
• Circulating Tumor Cells and Breast Cancer Metastasis: From Enumeration to Somatic Mutational Profile

  2022cites this paper
• Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors

  2022cites this paper
• Activity Map and Transition Pathways of G Protein-Coupled Receptor Revealed by Machine Learning

  2022cites this paper
• PET Imaging of the Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68

  2022cites this paper
• Development of a Neurotensin-Derived 68Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS1 Receptor-Expressing Tumors

  2022cites this paper
• Neurotensin is an anti-thermogenic peptide produced by lymphatic endothelial cells.

  2021cites this paper
• The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy

  2021cites this paper
• Sweetening Pharmaceutical Radiochemistry by 18F-Fluoroglycosylation: Recent Progress and Future Prospects

  2021cites this paper
• The Neurotensinergic System: A Target for Cancer Treatment.

  2021cites this paper
• Expression of neurotensin receptor-1 (NTS1) in primary breast tumors, cellular distribution, and association with clinical and biological factors

  2021cites this paper
• Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with 68Ga-Labeled Antagonists: The Chelate Makes the Difference Again.

  2021cites this paper
• Neurotensin: A novel mediator of ovulation?

  2021cites this paper
• Suppression of the NTS-CPS1 regulatory axis by AFF1 in lung adenocarcinoma cells

  2021cites this paper
• Optimizing the Profile of [99mTc]Tc–NT(7–13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors

  2020cites this paper
• Neurotensins and their therapeutic potential: research field study.

  2020cites this paper
• Neurotensin receptor 1 signaling promotes pancreatic cancer progression

  2020cites this paper
• Preclinical PET Imaging of NTSR-1-Positive Tumors with 64Cu- and 68Ga-DOTA-Neurotensin Analogs and Therapy with an 225Ac-DOTA-Neurotensin Analog

  2020cites this paper
• 1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity

  2020cites this paper
• Characterisation of the Expression of Neurotensin and Its Receptors in Human Colorectal Cancer and Its Clinical Implications

  2020cites this paper
• Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD.

  2020cites this paper
• Role of Neurotransmitters and Neuropeptides in Breast Cancer Metastasis

  2020cites this paper
• Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

  2020cites this paper
• Structural modifications of amino acid sequences of radiolabeled peptides for targeted tumor imaging.

  2020cites this paper
• The role of Neurotensin and its receptors in non-gastrointestinal cancers: a review

  2020cites this paper
• Neurotensin Receptor-1 Expression in Human Prostate Cancer: A Pilot Study on Primary Tumors and Lymph Node Metastases

  2019influential citation
• Hydrophilic 18F-labeled trans-5-oxocene (oxoTCO) for efficient construction of PET agents with improved tumor-to-background ratios in neurotensin receptor (NTR) imaging.

  2019cites this paper
• Neurotensin promotes cholangiocarcinoma metastasis via the EGFR/AKT pathway.

  2019cites this paper
• In vivo assembly and large-scale purification of a GPCR - Gα fusion with Gβγ, and characterization of the active complex

  2019cites this paper
• Fluorescence Labeling of Neurotensin(8–13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity

  2019cites this paper
• Construction of competing endogenous RNA networks from paired RNA-seq data sets by pointwise mutual information

  2019cites this paper
• Abstract. Oral squamous cell carcinoma (OSCC) is a major type of malignant tumor of the oral cavity. Despite marked advances in the management and diagnosis of OSCC,

  2019cites this paper
• Screening and identification of biomarkers associated with clinicopathological parameters and prognosis in oral squamous cell carcinoma

  2019cites this paper
• Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth

  2019cites this paper
• Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS1 Receptor Affinity.

  2019cites this paper
• Exploratory Analysis of Plasma Neurotensin as a Novel Biomarker for Early Detection of Colorectal Polyp and Cancer

  2019cites this paper
• Development of Bispecific NT-PSMA Heterodimer for Prostate Cancer Imaging: A Potential Approach to Address Tumor Heterogeneity.

  2019cites this paper
• Preclinical Evaluation of 68Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis.

  2019cites this paper
• No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunction

  2018cites this paper
• Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer

  2018influential citation
• No effect of administration of unacylated ghrelin on subcutaneous PC3 xenograft growth in a Rag1−/− mouse model of metabolic dysfunction

  2018cites this paper
• Rôle de la neurotensine dans la progression des adénocarcinomes de l’endomètre et de l’ovaire

  2018influential citation
• Flow‐Assisted Synthesis: A Key Fragment of SR 142948A

  2017cites this paper
• Neurotensin and Neurotensin Receptors in health and diseases: A brief review

  2017cites this paper
• Caractérisation fonctionnelle du récepteur de type 2 de la neurotensine dans la résistance à la mort cellulaire des lymphocytes B au cours de la Leucémie Lymphoïde Chronique

  2017cites this paper
• The signaling signature of the neurotensin type 1 receptor with endogenous ligands

  2017cites this paper
• Development of Neurotensin-Based Radiopharmaceuticals For Neurotensin-Receptor-1-Positive Tumors Targeting

  2017cites this paper
• A Review of the Role of Neurotensin and Its Receptors in Colorectal Cancer

  2017influential citation
• NTS2-selective neurotensin mimetics with tetrahydrofuran amino acids.

  2017cites this paper
• Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome

  2017cites this paper
• Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors

  2017cites this paper
• Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells

  2017influential citation
• Proof of Therapeutic Efficacy of a 177Lu-Labeled Neurotensin Receptor 1 Antagonist in a Colon Carcinoma Xenograft Model

  2017cites this paper
• Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer

  2017cites this paper
• Oncogenic role of neurotensin and neurotensin receptors in various cancers

  2017cites this paper
• Molecular imaging probes derived from natural peptides.

  2016cites this paper
• NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma

  2016cites this paper
• Copy number and expression analysis of FOSL1, GSTP1, NTSR1, FADD and CCND1 genes in primary breast tumors with axillary lymph node metastasis.

  2016cites this paper
• Structure–Activity Relationship Studies of Amino Acid Substitutions in Radiolabeled Neurotensin Conjugates

  2016cites this paper
• Stereoselective Synthesis of β‐(5‐Arylthiazolyl) α‐Amino Acids and Use in Neurotensin Analogues

  2016cites this paper
• Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.

  2015cites this paper
• Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer

  2015influential citation
• 1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.

  2015cites this paper
• Tu1908 Differential Expression and Tumorigenic Function of Neurotensin Receptor 1 in Neuroendocrine Tumor Cells

  2015cites this paper
• Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor.

  2015cites this paper
• Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.

  2015cites this paper
• Neurotensin:a candidate for peptide-guideddrug delivery

  2015cites this paper
• Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells

  2015cites this paper
• Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients

  2015cites this paper
• The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells

  2015cites this paper
• The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1

  2015cites this paper
• A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties

  2015cites this paper
• Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice

  2014cites this paper
• Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors

  2014cites this paper
• Identification of Novel Neurotensin Receptor 1 Inhibitors by Combinatorial Support Vector Machine

  2014cites this paper
• Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients

  2014cites this paper
• Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice

  2014cites this paper
• Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway

  2014cites this paper
• Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib

  2014cites this paper
• Single-photon emission computed tomography tracers for predicting and monitoring cancer therapy.

  2014cites this paper
• Validation of Plasma Proneurotensin as a Novel Biomarker for the Prediction of Incident Breast Cancer

  2014cites this paper
• Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.

  2014cites this paper
• Facile Preparation of a Thiol-Reactive 18F-Labeling Agent and Synthesis of 18F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor–Positive Tumor

  2014cites this paper
• Neurotensin Receptor 1 (NTSR1) Overexpression in Breast Carcinomas Is Common and Independent of ER/PR/Her2 Expression

  2013cites this paper
• Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

  2013cites this paper
• Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells

  2013cites this paper
• The synthesis of neurotensin antagonist SR 48692 for prostate cancer research.

  2013cites this paper
• Molecular Orientation of Neurotensin and Its Single-Site Mutants on a Colloidal Silver Surface: SERS Studies

  2012cites this paper